Edwards Lifesciences Corp (EW)
Fixed asset turnover
Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue (ttm) | US$ in thousands | 5,724,300 | 5,872,600 | 5,999,100 | 6,143,400 | 6,004,800 | 5,819,000 | 5,657,100 | 5,500,800 | 5,382,400 | 5,363,800 | 5,355,000 | 5,357,100 | 5,232,500 | 5,094,500 | 4,925,200 | 4,474,200 | 4,386,300 | 4,368,700 | 4,321,800 | 4,483,700 |
Property, plant and equipment | US$ in thousands | — | — | — | — | — | 1,772,200 | 1,747,100 | 1,646,000 | 1,725,100 | 1,654,100 | 1,644,100 | 1,552,200 | 1,638,700 | 1,549,400 | 1,530,400 | 1,417,900 | 1,395,200 | 1,276,300 | 1,195,600 | 1,100,600 |
Fixed asset turnover | — | — | — | — | — | 3.28 | 3.24 | 3.34 | 3.12 | 3.24 | 3.26 | 3.45 | 3.19 | 3.29 | 3.22 | 3.16 | 3.14 | 3.42 | 3.61 | 4.07 |
December 31, 2024 calculation
Fixed asset turnover = Revenue (ttm) ÷ Property, plant and equipment
= $5,724,300K ÷ $—K
= —
The fixed asset turnover ratio measures how efficiently a company generates sales revenue from its investment in fixed assets. For Edwards Lifesciences Corp, the trend in the fixed asset turnover ratio has shown some variability over the past few years.
From March 31, 2020, with a ratio of 4.07, the company's fixed asset turnover gradually decreased, reaching a low of 3.12 on December 31, 2022. This decline indicates a decrease in the company's efficiency in utilizing its fixed assets to generate sales.
However, the ratio started to pick up again in the following periods, showing signs of improvement. As of March 31, 2024, the fixed asset turnover ratio was not available in the data provided.
Overall, the trend in Edwards Lifesciences Corp's fixed asset turnover ratio demonstrates fluctuations but with a general trend of moderate efficiency in utilizing fixed assets to generate sales, with some periods of improvement after a decline. It would be important to closely monitor future data points to assess the company's ongoing asset utilization efficiency.
Peer comparison
Dec 31, 2024
See also:
Edwards Lifesciences Corp Net Fixed Asset Turnover (Quarterly Data)